Efficacy and safety of linagliptin (BI 1356), a novel inhibitor of dipeptidyl-peptidase 4 (DPP-4), in animal models and clinical studies in healthy volunteers and patients with type 2 diabetes mellitus - Rauch, Thomas (Heidelberg, Univ., Diss., 2012, 2010)